1)Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today. 1997; 18: 519-21
|
|
|
2)Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003; 133: 1452S-6S
|
|
|
3)Kury S, Dreno B, Bezieau S, et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet. 2002; 31: 239-40
|
|
|
4)Huang L, Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet. 1997; 17: 292-7
|
|
|
5)Chowanadisai W, Lonnerdal B, Kelleher SL. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem. 2006; 281: 39699-707
|
|
|
6)DePasquale-Jardieu P, Fraker PJ. The role of corticosterone in the loss in immune function in the zinc-deficient A/J mouse. J Nutr. 1979; 109: 1847-55
|
|
|
7)DePasquale-Jardieu P, Fraker PJ. Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J Immunol. 1980; 124: 2650-5
|
|
|
8)King LE, Osati-Ashtiani F, Fraker PJ. Apoptosis plays a distinct role in the loss of precursor lymphocytes during zinc deficiency in mice. J Nutr. 2002; 132: 974-9
|
|
|
9)Hirano T, Murakami M, Fukada T, et al. Roles of zinc and zinc signaling in immunity: Zinc as an intracellular signaling molecule. Advanced Immunology. In press
|
|
|
10)Kabu K, Yamasaki S, Kamimura D, et al. Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol. 2006; 177: 1296-305
|
|
|
11)Yamasaki S, Sakata-Sogawa K, Hasegawa A. Zinc is a novel intracellular second messenger. J Cell Biol. 2007; 177: 637-45
|
|
|
12)von Bulow V, Rink L, Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-α and IL-1β production in monocytes by elevation of cGMP. J Immunol. 2005; 175: 4697-705
|
|
|
13)Kitamura H, Morikawa H, Kamon H, et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol. 2006; 7: 971-7
|
|
|
14)Cousins RJ, Liuzzi JP, Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem. 2006; 281: 24085-9
|
|
|
15)Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta. 2006; 1763: 711-22
|
|
|
16)Wellinghausen N, Martin M, Rink L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur J Immunol. 1997; 27: 2529-35
|
|
|
17)Zhou Z, Wang L, Song Z, et al. Abrogation of nuclear factor-κB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-α production and liver injury. Am J Pathol. 2004; 164: 1547-56
|
|
|
18)Snyder SL, Walker RI. Inhibition of lethality in endotoxin-challenged mice treated with zinc chloride. Infect Immun. 1976; 13: 998-1000
|
|
|
19)Shea-Budgell M, Dojka M, Nimmo M, et al. Marginal zinc deficiency increased the susceptibility to acute lipopolysaccharide-induced liver injury in rats. Exp Biol Med. 2006; 231: 553-8
|
|
|
20)Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr. 2003; 133: 1460S-2S
|
|
|
21)Maret W, Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA. 1998; 95: 3478-82
|
|
|
22)Leibbrandt ME, Koropatnick J. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc. Toxicol Appl Pharmacol. 1994; 124: 72-81
|
|
|